HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Comment by fairweather1on May 02, 2013 5:12pm

99 Views

Post# 21331480

RE: RE: Ontario budget released

I read the same article, and that is the closest I have come to finding any comment related to oakville and the innovation fund.

We haven't seen a clear statement, but you would expect it to be one of the main points in any summaries of the budget. So I'm assuming no....not that that means Ford is going to close up shop or cut off AM, but it doesn't help our cause.

Bullboard Posts

Opawica seeks drill permits for Bazooka Gold Targets in Abitibi